Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.89
-0.4700-1.37%
Post-market: 33.920.0300+0.09%19:59 EDT
Volume:1.50M
Turnover:51.30M
Market Cap:3.95B
PE:-7.26
High:34.98
Open:34.79
Low:33.47
Close:34.36
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.91
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.68
PE(LYR):-10.62

Loading ...

Viking says oral VK2735 cuts weight up to 12.2% in Phase 2 trial

Reuters
·
May 12

BRIEF-Viking Therapeutics Presents Data From Its 13-Week Phase 2 Venture-Oral Dosing Trial

Reuters
·
May 12

Viking Therapeutics Presents Data From Its 13-Week Phase 2 Venture-Oral Dosing Trial of Vk2735 at European Congress on Obesity (Eco) 2026

THOMSON REUTERS
·
May 12

Viking Therapeutics presents Phase 2 oral VK2735 weight-loss data at ECO 2026

Reuters
·
May 05

Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (Eco) 2026

THOMSON REUTERS
·
May 05

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
May 05

Viking Therapeutics Price Target Maintained With a $125.00/Share by BTIG

Dow Jones
·
May 04

Maxim Group Sticks to Its Buy Rating for Viking Therapeutics (VKTX)

TIPRANKS
·
May 01

Ligand Pharma Ends TR‑Beta License With Viking Therapeutics

TIPRANKS
·
May 01

Ligand, Viking dispute TR-Beta program termination under license agreement

Reuters
·
May 01

Viking Therapeutics Q1 Viewed as Supporting Maintenance Profile, Oppenheimer Says

MT Newswires Live
·
May 01

Viking Therapeutics price target lowered to $95 from $99 at Morgan Stanley

TIPRANKS
·
Apr 30

Viking Therapeutics Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Apr 30

Chefs' Warehouse Inc : Morgan Stanley Raises Target Price to $83.00 From $76.00

THOMSON REUTERS
·
Apr 30

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Viking Therapeutics (VKTX)

TIPRANKS
·
Apr 30

Earnings Flash (VKTX) Viking Therapeutics Posts Q1 EPS -$1.37, vs. FactSet Est of -$0.98

MT Newswires Live
·
Apr 30

Viking Therapeutics reports Q1 EPS ($1.37), consensus (91c)

TIPRANKS
·
Apr 30

Viking Therapeutics Q1 loss widens on  higher research, development expenses

Reuters
·
Apr 30

Viking Therapeutics Q1 EPS $(1.37) Misses $(1.02) Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Viking Therapeutics Q1 EPS USD -1.37 Vs. IBES Estimate USD -1.01

Reuters
·
Apr 30